Skip to main content
. Author manuscript; available in PMC: 2022 Apr 8.
Published in final edited form as: Acc Chem Res. 2021 Aug 20;54(17):3462–3475. doi: 10.1021/acs.accounts.1c00359

Figure 7.

Figure 7.

Drugs and drug-like compounds that bind MR1 and activate or inhibit MAIT TCR or upregulate MR1 expression in antigen-presenting cells, and PDB codes for ligand−protein crystal structures (PDB 5U1R, 5U72, 5U17, 5U16, and 5U6Q). Data from ref 4.